AmeriFlex Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26K Buy
+65
New +$4.49K 0.01% 696

Other funds holding XPH

AmeriFlex Group's XPH Position: Q3 2026 in Review

AmeriFlex Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 65 shares worth $26K. The stake represents 0.01% of the portfolio and ranks #696 among its holdings.

107 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • AmeriFlex Group held 65 shares of State Street SPDR S&P Pharmaceuticals ETF worth $26K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new AmeriFlex Group position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of AmeriFlex Group's portfolio in Q3 2026, its #696 holding.
  • 107 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.